Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in Amyotrophic Lateral Sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia.
Administration of mesenchymal stromal cells (MSC) improves functional outcome in the SOD1G93A mouse model of the degenerative motor neuron disorder amyotrophic lateral sclerosis (ALS) as well as in models of other neurological disorders. We have now investigated the effect of the interaction between...
Guardado en:
Autores principales: | Hui Sun, Karelle Bénardais, Nancy Stanslowsky, Nadine Thau-Habermann, Niko Hensel, Dongya Huang, Peter Claus, Reinhard Dengler, Martin Stangel, Susanne Petri |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/35457bc4720b499aac82aaaa09510700 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Establishment of a consensus definition for mesenchymal stromal cells (MSC) and reporting guidelines for clinical trials of MSC therapy: a modified Delphi study protocol
por: Kelly D Cobey, et al.
Publicado: (2021) -
Dysfunction of RNA/RNA-Binding Proteins in ALS Astrocytes and Microglia
por: Simona Rossi, et al.
Publicado: (2021) -
NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
por: Markéta Šašinková, et al.
Publicado: (2021) -
Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis
por: Amit Pal, et al.
Publicado: (2021) -
Microglia astrocyte interaction in Alzheimer's disease: friends or foes for the nervous system?
por: VON BERNHARDI,ROMMY, et al.
Publicado: (2001)